M.G. Mumolo

1.1k total citations
37 papers, 778 citations indexed

About

M.G. Mumolo is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, M.G. Mumolo has authored 37 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in M.G. Mumolo's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (13 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). M.G. Mumolo is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (13 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). M.G. Mumolo collaborates with scholars based in Italy, Switzerland and United States. M.G. Mumolo's co-authors include Francesco Costa, Massimo Bellini, Santino Marchi, Lorenzo Bertani, Linda Ceccarelli, Nicola de Bortoli, Gherardo Tapete, Eleonora Albano, Angelo Ricchiuti and Corrado Blandizzi and has published in prestigious journals such as Gastroenterology, PLoS ONE and The American Journal of Gastroenterology.

In The Last Decade

M.G. Mumolo

35 papers receiving 762 citations

Peers

Countries citing papers authored by M.G. Mumolo

Since Specialization

Citations

This map shows the geographic impact of M.G. Mumolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Mumolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Mumolo more than expected).

Fields of papers citing papers by M.G. Mumolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Mumolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Mumolo. The network helps show where M.G. Mumolo may publish in the future.

Co-authorship network of co-authors of M.G. Mumolo

This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Mumolo. A scholar is included among the top collaborators of M.G. Mumolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Mumolo. M.G. Mumolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn’s Disease 2023 ·Journal of Clinical Medicine ·Lorenzo Bertani, Claudia D’Alessandro, Marco Fornili, (unknown), Federico Zanzi, Luca Carmisciano, (unknown), (unknown), (unknown), (unknown), Linda Ceccarelli, M.G. Mumolo, Laura Baglietto, Massimo Bellini, Nicola de Bortoli, Francesco Costa	0
2	Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry 2021 ·Inflammatory Bowel Diseases ·Gherardo Tapete, Lorenzo Bertani, (unknown), Erica Nicola Lynch, M. Giannotta, Riccardo Morganti, (unknown), (unknown), M.G. Mumolo, Francesca De Nigris, Francesca Calella, Siro Bagnoli, (unknown), S. Maltinti, (unknown), Linda Ceccarelli, Paolo Lionetti, Mónica Milla, Francesco Costa	27
3	Hospitalisation for Drug Infusion Did Not Increase Levels of Anxiety and the Risk of Disease Relapse in Patients with Inflammatory Bowel Disease during COVID-19 Outbreak 2021 ·Journal of Clinical Medicine ·Lorenzo Bertani, Brigida Barberio, Domenico Tricò, Federico Zanzi, Daria Maniero, Linda Ceccarelli, Ilaria Marsilio, (unknown), Greta Lorenzon, M.G. Mumolo, Fabiana Zingone, Francesco Costa, Edoardo Savarino	1
4	Inflammatory Bowel Diseases: Is There a Role for Nutritional Suggestions? 2021 ·Nutrients ·Lorenzo Bertani, Davide Giuseppe Ribaldone, Massimo Bellini, M.G. Mumolo, Francesco Costa	24
5	Serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 2020 ·Alimentary Pharmacology & Therapeutics ·Lorenzo Bertani, Domenico Tricò, Daniela Pugliese, Giuseppe Privitera, Giuseppe Linsalata, Federico Zanzi, M.G. Mumolo, Brigida Barberio, Fabio Monzani, Santino Marchi, Luisa Guidi, Corrado Blandizzi, Alessandro Armuzzi, Francesco Costa	17
6	Is Gluten the Only Culprit for Non-Celiac Gluten/Wheat Sensitivity? 2020 ·Nutrients ·M.G. Mumolo, (unknown), (unknown), Francesco Costa, Angelo Ricchiuti, Linda Ceccarelli, Nicola de Bortoli, Santino Marchi, Massimo Bellini	27
7	Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 2020 ·British Journal of Clinical Pharmacology ·Lorenzo Bertani, Laura Baglietto, Luca Antonioli, Matteo Fornai, Gherardo Tapete, Eleonora Albano, Linda Ceccarelli, M.G. Mumolo, Carolina Pellegrini, Ersilia Lucenteforte, Nicola de Bortoli, Massimo Bellini, Santino Marchi, Corrado Blandizzi, Francesco Costa	35
8	Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 2019 ·Digestive Diseases and Sciences ·Lorenzo Bertani, Giorgia Bodini, M.G. Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi, Francesco Costa	9
9	From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting 2018 ·World Journal of Gastroenterology ·M.G. Mumolo, Lorenzo Bertani, Linda Ceccarelli, (unknown), (unknown), Eleonora Albano, Gherardo Tapete, Francesco Costa	133
10	Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 2017 ·Techniques in Coloproctology ·Massimo Bellini, Dario Gambaccini, L. Bazzichi, Gabrio Bassotti, M.G. Mumolo, (unknown), Francesco Costa, Angelo Ricchiuti, Nicola de Bortoli, Marta Mosca, Santino Marchi, Alessandra Rossi	14
11	P.13.13 DYNAMIC TRANSPERINEAL ULTRASOUND FOR THE EVALUATION OF PELVIC FLOOR DISORDERS: WHICH IS THE BEST POSITION? 2016 ·Digestive and Liver Disease ·A. Ricchiuti, Dario Gambaccini, (unknown), (unknown), M.G. Mumolo, G. Ricco, (unknown), Patrizia Giusti, Nicola de Bortoli, Stefano F. de Marchi, Massimo Bellini	1
12	Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 2013 ·International Journal of Colorectal Disease ·Cristina Stasi, Massimo Bellini, Francesco Costa, M.G. Mumolo, Angelo Ricchiuti, M Grosso, Emiliano Duranti, (unknown), Dario Gambaccini, (unknown), Gian Luca Di Tanna, Giacomo Laffi, Stefano Taddei, Santino Marchi	24
13	Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome 2013 ·PLoS ONE ·Rocchina Colucci, Dario Gambaccini, Narcisa Ghisu, Giuseppe Rossi, Francesco Costa, Marco Tuccori, Nicola de Bortoli, Matteo Fornai, Luca Antonioli, Angelo Ricchiuti, M.G. Mumolo, Santino Marchi, Corrado Blandizzi, Massimo Bellini	38
14	Management of chronic constipation in general practice 2013 ·Techniques in Coloproctology ·Massimo Bellini, Dario Gambaccini, Stefano Salvadori, Cesare Tosetti, (unknown), Francesco Costa, (unknown), M.G. Mumolo, Angelo Ricchiuti, Nicola de Bortoli, Santino Marchi	17
15	Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 2011 ·Alimentary Pharmacology & Therapeutics ·Nicola de Bortoli, Irene Martinucci, Paolo Piaggi, S. Maltinti, (unknown), Eugenio Ciancia, Dario Gambaccini, (unknown), Francesco Costa, Giulia C. Leonardi, Angelo Ricchiuti, M.G. Mumolo, Massimo Bellini, Corrado Blandizzi, Santino Marchi	12
16	Helicobacter pylori Eradication: A Randomized Prospective Study of Triple Therapy Versus Triple Therapy Plus Lactoferrin and Probiotics 2007 ·The American Journal of Gastroenterology ·Nicola de Bortoli, Giulia C. Leonardi, Eugenio Ciancia, (unknown), Massimo Bellini, Francesco Costa, M.G. Mumolo, Angelo Ricchiuti, (unknown), Stefano Santi, Mauro Rossi, Santino Marchi	98
17	Increased levels of neuropeptidey in patients with irritable bowel syndrome 2006 ·Digestive and Liver Disease ·Cristina Stasi, Alberto Frisoli, Massimo Bellini, Stefano Taddei, (unknown), (unknown), Stefania Favilla, M.G. Mumolo, (unknown), Santino Marchi	1
18	Platelet Serotonin Transporter in Patients With Diarrhea-Predominant Irritable Bowel Syndrome Both Before and After Treatment With Alosetron 2003 ·The American Journal of Gastroenterology ·Massimo Bellini, (unknown), Corrado Blandizzi, Francesco Costa, Cristina Stasi, Rocchina Colucci, Gino Giannaccini, Donatella Marazziti, Laura Betti, Stefano Baroni, M.G. Mumolo, Santino Marchi, Mario Del Tacca	51
19	Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection 2001 ·European Journal of Gastroenterology & Hepatology ·Santino Marchi, Francesco Costa, Massimo Bellini, (unknown), M.G. Mumolo, (unknown), Roberto Spisni, (unknown), G. Maltinti	13
20	Post-traumatic inflammatory pseudotumor of the esophagus 2001 ·Gastrointestinal Endoscopy ·Santino Marchi, Francesco Costa, M.G. Mumolo, Massimo Bellini, Eugenio Ciancia, Patrizia Giusti, G. Maltinti	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact